
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
OPINION
Modern tumor imaging models for rodents: potential and prospects in translational medicine
1 Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia
2 Pirogov Russian National Research Medical University, Moscow, Russia
Correspondence should be addressed: Nadezhda M. Myshkina
Miklukho-Maklaya, 16/10, Moscow, 117997, Russia; moc.liamg@aydan.anikram
Funding: the study was supported by the Russian Science Foundation grant, project No. 24-74-10105 (https://rscf.ru/project/24-74-10105/).
Author contribution: Fadeeva AA — literature review, manuscript writing; Myshkina NM — paper concept, literature review, manuscript writing, project management; Chepurnykh TV — manuscript writing and editing; Osipova ZM — data processing, manuscript editing.
Rodent neoplastic process models are extensively used in pre-clinical practice to assess the dynamics of tumor development and test anti-cancer drugs, which ensures flexibility of choosing both basic and advanced personalized tumor development models for researchers. Various modern model tumor imaging methods are considered, including fluorescence and bioluminescence imaging, which enable comprehensive assessment, from qualitative evaluation to in vivo monitoring. We believe that the development of autonomous bioluminescent systems in mammalian cells will provide new possibilities for noninvasive imaging of animal physiological processes, including long-term monitoring of tumor progression.
Keywords: bioluminescence, bioimaging, biomedical research, autonomous bioluminescence, tumor models